Skip to main content
Signal8

Rosenberg Aaron

SEC insider (Form 3/4/5 filer). CIK 0002031182. Chief Financial Officer at BeOne Medicines Ltd. (ONC). 8 reported Form 4/5 transactions since Sep 2024; latest on Aug 3, 2026. Located in BASEL.

Companies Rosenberg Aaron has filed insider reports for

  • BeOne Medicines Ltd. (ONC): Officer, Chief Financial Officer
Rosenberg Aaron profile photo

Rosenberg Aaron

CIK: 0002031182

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (37.5%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (62.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BeOne Medicines Ltd. logo
ONC

BeOne Medicines Ltd.

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

  • BeOne Medicines Ltd. logo
    ONC

    BeOne Medicines Ltd.

    Aug 3, 2026
    Sale
    Direct
    1.2K shares at avg. $312.71$362K
  • BeOne Medicines Ltd. logo
    ONC

    BeOne Medicines Ltd.

    Jun 11, 2026
    Award
    Direct
    71.2K shares-
  • BeOne Medicines Ltd. logo
    ONC

    BeOne Medicines Ltd.

    Jun 11, 2026
    Sale
    Direct
    631 shares at avg. $257.74$163K
  • BeOne Medicines Ltd. logo
    ONC

    BeOne Medicines Ltd.

    Mar 6, 2026
    Award
    Direct
    40.6K shares-
  • BeOne Medicines Ltd. logo
    ONC

    BeOne Medicines Ltd.

    Mar 6, 2026
    Award
    Direct
    79K shares-
  • BeOne Medicines Ltd. logo
    ONC

    BeOne Medicines Ltd.

    Aug 1, 2025
    Sale
    Direct
    1.2K shares at avg. $290.47$346K
  • BeOne Medicines Ltd. logo
    ONC

    BeOne Medicines Ltd.

    Jun 10, 2025
    Award
    Direct
    63.7K shares-
  • BeiGene, Ltd. logo
    BGNE

    BeiGene, Ltd.

    Mar 5, 2025
    Award
    Direct
    48.6K shares-

1-8 of 8